PLX
Protalix BioTherapeutics (PLX)
$48
About Protalix BioTherapeutics (PLX)
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.19
52 Week Low
$1.46
Market cap
196.6M
Dividend yield
0.00%
Volume
--
Avg. volume
581,542
P/E ratio
13.31
Protalix BioTherapeutics News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$3.19
52 Week Low
$1.46
Market cap
196.6M
Dividend yield
0.00%
Volume
--
Avg. volume
581,542
P/E ratio
13.31